Beneficial effect of the SGLT-2 inhibitor empagliflozin on glucose homeostasis and cardiovascular parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) rat - Younis, F M; Leor, J; Abassi, Z (J Cardiovasc Pharmacol Ther, 2018)
. doi:10.1177/1074248418763808